MMP9 and colorectal carcinoma: In conclusion, the present results demonstrated that the core active components are apigenin and naringenin, and the core targets are PTGS2 and MMP-9 when D. officinale exerts antitumor effects on CRC through a combination of network pharmacology, metabolomics, and molecular docking.